Narachi Michael
President and CEO at Orexigen Therapeutics, Inc.
- Sold, on record
- $3.5M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Jul 17, 2012
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Orexigen Therapeutics, Inc.President and CEO
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Orexigen Therapeutics, Inc.UnusualJun 29, 2012 2012
Sold 225,000 shares at $5.89 ($1.3M)
Narachi Michael, President and CEO
Sold 100% of holdings ($1.3M position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale Orexigen Therapeutics, Inc.UnusualJul 13, 2012 +14 days
Sold 150,000 shares at $6.70 ($1M)
Narachi Michael, President and CEO
Sold 100% of holdings ($1M position)0 shares leftFiling
- 3 Form 4 sale Orexigen Therapeutics, Inc.UnusualJul 17, 2012 +4 days
Sold 150,000 shares at $7.66 ($1.1M)
Narachi Michael, President and CEO
Sold 100% of holdings ($1.1M position)0 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2012 | Jul 19, 2012 | Orexigen Therapeutics, Inc. | President and CEO | Form 4 sale | 150,000 | $1.1M | 100.0% | Unusual | SEC |
| Jul 13, 2012 | Jul 13, 2012 | Orexigen Therapeutics, Inc. | President and CEO | Form 4 sale | 150,000 | $1M | 100.0% | Unusual | SEC |
| Jun 29, 2012 | Jun 29, 2012 | Orexigen Therapeutics, Inc. | President and CEO | Form 4 sale | 225,000 | $1.3M | 100.0% | Unusual | SEC |